Roland B. Walter, MD, PhD, MS
Assistant Professor, Hematology
Adjunct Assistant Professor, Epidemiology
Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
Dr. Walter is an Assistant Professor of Medicine, University of Washington, Division of Hematology. His laboratory research is focused on human acute myeloid leukemia (AML), in particular on the delineation of the clonal origin of AML, the molecular and phenotypic characterization of AML stem and progenitor cells, and the interaction between AML cells in their environment. A long-term goal of his preclinical studies is the development of novel therapeutic strategies aimed to eradicate AML stem and progenitor cells. Findings from such studies are then translated into the clinic and tested in early phase human trials.
A second research interest of Dr. Walter is the development and conduct of clinical trials in AML. Dr. Walter is currently the Principal Investigator of several early phase clinical trials that test new drugs and drug combinations in AML; some of these trials were the direct consequence of his prior laboratory studies. He also leads a phase 2 study that explores a strategy of outpatient management of selected AML/MDS patients following intensive induction chemotherapy.
Fred Hutchinson Cancer Research Center
100 Fairview Ave. N., D2-190
Seattle, WA 98109-1024
Acute myeloid leukemia; Gemtuzumab Ozogamicin; Immunotherapy of AML; Leukemia Stem Cells; Clinical Trials in AML
MS, Epidemiology (Clinical Research), University of Washington, School of Public Health 2011
PhD, Experimental Pathology, University of Washington 2006
MD, Medicine, University of Zurich (Switzerland) 1997
SciVal Experts Page